Literature DB >> 20232365

Naturally occurring asteriscunolide A induces apoptosis and activation of mitogen-activated protein kinase pathway in human tumor cell lines.

Gledy Negrín1, José L Eiroa, Manuel Morales, Jorge Triana, José Quintana, Francisco Estévez.   

Abstract

Sesquiterpene lactones have attracted much attention because they display a wide range of biological activities, including antitumor properties. Here, we show the effects of the naturally occurring sesquiterpene lactone asteriscunolide A (AS) on viability of human melanoma, leukemia and cells that overexpress antiapoptotic proteins, namely Bcl-2 and Bcl-x(L). All cell lines were sensitive to this compound, with IC(50) values of approximately 5 microM. The cytotoxic effects of AS were accompanied by a G(2)-M phase arrest of the cell cycle and a concentration- and time-dependent appearance of apoptosis as determined by DNA fragmentation, translocation of phosphatidylserine to the cell surface and sub-G(1) ratio. Apoptosis was associated with caspase-3 activity and poly(ADP-ribose) polymerase cleavage and was prevented by the nonspecific caspase inhibitor z-VAD-fmk, indicating that caspases are essential components in this pathway. The apoptotic effect of AS was also associated with (i) the release of cytochrome c from mitochondria which was accompanied by dissipation of the mitochondrial membrane potential (Delta Psi(m)) and (ii) the activation of the mitogen-activated protein kinases (MAPKs) pathway. AS-induced cell death was potentiated by inhibition of extracellular signal-regulated kinases (ERK) 1/2 signaling with U0126 and PD98059. Intracellular reactive oxygen species (ROS) seem to play a pivotal role in this process since high levels of ROS were produced early (1 h) and apoptosis was completely blocked by the free radical scavenger N-acetyl-L-cysteine (NAC). The present study demonstrates that AS-induced cell death is mediated by an intrinsic-dependent apoptotic event involving mitochondria and MAPKs, and through a mechanism dependent on ROS generation. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232365     DOI: 10.1002/mc.20629

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

1.  Thionium ion initiated medium-sized ring formation: the total synthesis of asteriscunolide D.

Authors:  Barry M Trost; Aaron C Burns; Mark J Bartlett; Thomas Tautz; Andrew H Weiss
Journal:  J Am Chem Soc       Date:  2012-01-10       Impact factor: 15.419

2.  The ER stress-mediated mitochondrial apoptotic pathway and MAPKs modulate tachypacing-induced apoptosis in HL-1 atrial myocytes.

Authors:  Jiaojiao Shi; Qi Jiang; Xiangwei Ding; Wenhua Xu; Dao W Wang; Minglong Chen
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

Review 3.  Mechanisms of Chromosome Congression during Mitosis.

Authors:  Helder Maiato; Ana Margarida Gomes; Filipe Sousa; Marin Barisic
Journal:  Biology (Basel)       Date:  2017-02-17

4.  Molecular Mode of Action of Asteriscus graveolens as an Anticancer Agent.

Authors:  Zainab Tayeh; Nativ Dudai; Alona Schechter; Vered Chalifa-Caspi; Simon Barak; Rivka Ofir
Journal:  Int J Mol Sci       Date:  2018-07-24       Impact factor: 5.923

5.  Asteriscus graveolens Extract in Combination with Cisplatin/Etoposide/Doxorubicin Suppresses Lymphoma Cell Growth through Induction of Caspase-3 Dependent Apoptosis.

Authors:  Zainab Tayeh; Rivka Ofir
Journal:  Int J Mol Sci       Date:  2018-07-30       Impact factor: 5.923

Review 6.  ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.

Authors:  Reiko Sugiura; Ryosuke Satoh; Teruaki Takasaki
Journal:  Cells       Date:  2021-09-22       Impact factor: 6.600

7.  Cold atmospheric plasma induces apoptosis in human colon and lung cancer cells through modulating mitochondrial pathway.

Authors:  Yanhong Wang; Xinyu Mang; Xuran Li; Zhengyu Cai; Fei Tan
Journal:  Front Cell Dev Biol       Date:  2022-07-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.